Cargando…
PSUN42 New-Onset Rheumatoid Arthritis After Surgical Treatment of Cushing Syndrome
BACKGROUND: Cushing syndrome (CS) is a rare endocrinopathy resulting from prolonged exposure to endogenous or exogenous glucocorticoids. CS can be subclinical or can present with an array of overt signs and symptoms. The goal of treatment in CS is to reestablish normal cortisol levels in the body by...
Autores principales: | Richstein, Ryan, Schulman-Rosenbaum, Rifka |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9706649/ http://dx.doi.org/10.1210/jendso/bvac150.264 |
Ejemplares similares
-
PSUN20 The ACSPIRE Trial: 11beta-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Inhibition for Autonomous Cortisol Secretion and Adrenal Cushing's Syndrome
por: Czerwiec, Frank S, et al.
Publicado: (2022) -
PSUN15 Recurrence of Benign Pheochromocytoma
por: Manas, F N U, et al.
Publicado: (2022) -
Cushing's syndrome, pheochromocytoma, or both?
por: Kullamaa, Liisa, et al.
Publicado: (2023) -
A Case of Iatrogenic Cushing’s Syndrome
por: Del Toro Diez, Andrea, et al.
Publicado: (2021) -
Unusual Presentation of Cyclic Cushing’s Syndrome
por: Morales Hernandez, Maria del Mar, et al.
Publicado: (2021)